Co-occurring genomic alterations in non-small-cell lung cancer

Frontiers Concurrent Genetic Alterations and Other Biomarkers

Multiplatform discovery and regulatory function analysis of

Increasing Therapy Options in Solid Tumours: A Consideration of Testing Methodologies in Non-small Cell Lung Cancer and Breast Cancer - European Medical Journal

Cells, Free Full-Text

Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies - ScienceDirect

Comprehensive genomic profile of Chinese lung cancer patients and

The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies - ScienceDirect

Spectrum of co-occurring and mutually exclusive genomic

IJMS, Free Full-Text

Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small

Impact of Quality of Life on Prognosis of Metastatic Non-Small Cell Lung Cancer: Is It Correlated to the Chemotherapy Regimen Used?

Variation in targetable genomic alterations in non-small cell lung